During the COVID-19 crisis, it is essential for drug manufacturers to start considering short-term relief for distributor partners and HCP offices. Begin by asking these questions.

What pharma and biotech professionals need to know about the Drug Supply Chain Security Act and new track-and-trace regulations. Full article published on Pharmaceutical Executive.

While the norm is to view an audit as a stressful, time-consuming experience, audits can paint a picture not visible to the naked eye and are a valuable exercise to gauge the current health of a pharmaceutical patient support program.

Q&A on how traditional pharmaceutical distribution must be transformed to meet the challenges of revolutionary Cell and Gene Therapies.

Pharmaceutical Executive worked with Archbow’s distribution experts, Kevin Cast, Rob Besse, and Paul Furgal, to find out which trends we should be watching as we welcome 2020.